Acadian Asset Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Acadian Asset Management’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,319	Closed	-$77K	–	1949
2024 Q1	$77K	Buy	+26,319	New	+$81.4K	﹤0.01%	1327

Acadian Asset Management's CYT Position: Q2 2024 in Review

Acadian Asset Management sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q2 2024, closing a stake of 26,319 shares — an estimated $77K sold.

Acadian Asset Management first reported a position in CYT in Q1 2024 and held it in 1 quarter. The position peaked at $77K in Q1 2024. 0 funds tracked by Wall St. Rank hold CYT as of Q2 2024.

Acadian Asset Management reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Acadian Asset Management sold 26,319 Cyteir Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $77K.
Acadian Asset Management first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Acadian Asset Management's Cyteir Therapeutics, Inc. Common Stock position peaked at $77K in Q1 2024.
0 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.